131 related articles for article (PubMed ID: 20731031)
1. [Expression of B7-H4 in prostate cancer and its clinical significance].
Qian Y; Yao HP; Shen L; Cheng LF; Zhang LH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):345-9. PubMed ID: 20731031
[TBL] [Abstract][Full Text] [Related]
2. B7-H4 is a potential prognostic biomarker of prostate cancer.
Li H; Piao L; Liu S; Cui Y; Xuan Y
Exp Mol Pathol; 2020 Jun; 114():104406. PubMed ID: 32088189
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
[TBL] [Abstract][Full Text] [Related]
4. B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma.
Chen LJ; Sun J; Wu HY; Zhou SM; Tan Y; Tan M; Shan BE; Lu BF; Zhang XG
Cancer Immunol Immunother; 2011 Jul; 60(7):1047-55. PubMed ID: 21519829
[TBL] [Abstract][Full Text] [Related]
5. Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer.
Jiang J; Zhu Y; Wu C; Shen Y; Wei W; Chen L; Zheng X; Sun J; Lu B; Zhang X
Cancer Immunol Immunother; 2010 Nov; 59(11):1707-14. PubMed ID: 20725832
[TBL] [Abstract][Full Text] [Related]
6. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.
Krambeck AE; Thompson RH; Dong H; Lohse CM; Park ES; Kuntz SM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10391-10396. PubMed ID: 16798883
[TBL] [Abstract][Full Text] [Related]
7. B7-H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer.
Zhu J; Chu BF; Yang YP; Zhang SL; Zhuang M; Lu WJ; Liu YB
Asian Pac J Cancer Prev; 2013; 14(5):3011-5. PubMed ID: 23803071
[TBL] [Abstract][Full Text] [Related]
8. RCD24, B7-H4 and PCNA expression and clinical significance in ovarian cancer.
Zheng C; Yang R
J BUON; 2019; 24(2):715-719. PubMed ID: 31128028
[TBL] [Abstract][Full Text] [Related]
9. [Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer].
Hong B; Qian Y; Yao HP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):511-6. PubMed ID: 24167131
[TBL] [Abstract][Full Text] [Related]
10. Expression of B7-H4 in endometrial cancer and its impact on patients' prognosis.
Gorzelnik K; Wasaznik-Jedras A; Wicherek L; Szubert S
Ginekol Pol; 2024; 95(4):252-258. PubMed ID: 37873922
[TBL] [Abstract][Full Text] [Related]
11. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
Kim NI; Park MH; Kweon SS; Lee JS
Pathobiology; 2020; 87(3):179-192. PubMed ID: 32088722
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases.
Qian Y; Sang Y; Wang FX; Hong B; Wang Q; Zhou X; Weng T; Wu Z; Zheng M; Zhang H; Yao H
Oncotarget; 2016 Nov; 7(44):72242-72249. PubMed ID: 27750217
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
Huang H; Li C; Ren G
Gene; 2017 Aug; 623():24-28. PubMed ID: 28412458
[TBL] [Abstract][Full Text] [Related]
14. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
[TBL] [Abstract][Full Text] [Related]
15. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
Kim GE; Kim NI; Park MH; Lee JS
Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
[TBL] [Abstract][Full Text] [Related]
16. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.
Zang X; Thompson RH; Al-Ahmadie HA; Serio AM; Reuter VE; Eastham JA; Scardino PT; Sharma P; Allison JP
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19458-63. PubMed ID: 18042703
[TBL] [Abstract][Full Text] [Related]
17. B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells.
Yao Y; Wang X; Jin K; Zhu J; Wang Y; Xiong S; Mao Y; Zhou L
J Neurooncol; 2008 Sep; 89(2):121-9. PubMed ID: 18478183
[TBL] [Abstract][Full Text] [Related]
18. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM
Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470
[TBL] [Abstract][Full Text] [Related]
20. Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas.
Niu N; Shen W; Zhong Y; Bast RC; Jazaeri A; Sood AK; Liu J
Hum Pathol; 2021 Jul; 113():20-27. PubMed ID: 33887301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]